Acadia Pharmaceuticals buy BiotechBee
Start price
03.01.23
/
60%
€15.65
Target price
31.12.25
€22.00
Performance (%)
23.98%
End price
05.05.23
€19.40
Summary
This prediction ended on 05.05.23 with a price of €19.40. The prediction had a final performance of 23.98%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acadia Pharmaceuticals | -1.831% | -1.831% | 40.610% | 43.141% |
| iShares Core DAX® | 0.721% | 4.566% | 24.333% | 64.224% |
| iShares Nasdaq 100 | -0.413% | 1.884% | 8.848% | 107.611% |
| iShares Nikkei 225® | 3.500% | 7.196% | 24.030% | 57.276% |
| iShares S&P 500 | 0.489% | 2.436% | 6.048% | 67.009% |
According to BiotechBee what are the pros and cons of Acadia Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year